Kestra Medical Technologies, Ltd.

NASDAQ:KMTS

Medical - Instruments & Supplies

Healthcare
$28.29 -0.37%

-$0.07 today

Market cap
$1.69B
Beta
0.83
P/E (TTM)
-6.9
EPS (TTM)
-$2.74
52W Low $13.25High $30.00

Volume 0.44M

Average 0.33M

KMTS Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Kestra Medical Technologies, Ltd.NASDAQ: KMTS

Gross Margin · Q3 FY2026 · quarter ended Jan 2026

Gross margin widens to 52.6%

Gross margin was 52.6% in Q3 FY2026, up 9.2 pp from a year earlier. On a trailing-twelve-month basis it was 48.8%, up 14.6 pp year over year.

Context

  • Gross margin widened in 2 of the last 2 fiscal years.
  • FY2025 was the highest level in the 3 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJan 2026
52.6%+1.9 pp QoQ
Last fiscal yearApr 2025
40.5%+39.2 pp YoY
LTMJan 2026
48.8%+14.6 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+9.2 pp——
1 year+39.2 pp——
3 years———
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
40.5%
Year-over-year change
+39.2pp

Gross Margin vs competitors

How KMTS compares with its peers on the latest reported figures

  • KMTS's LTM Jan 2026 gross margin of 48.8% is the lowest of the 3 companies compared; the peer median is 78.9%.
  • Its year-over-year change of +14.6 pp is the highest of 3, against a peer median of +1.9 pp.
KMTS Competitors Peer median
Gross Margin for KMTS and competitors
Company Period LTM level YoY 3-year change
CVRXCVRx, Inc.LTM Mar 202685.5% +1.8 pp+7.6 pp
IRTCiRhythm Technologies, Inc.LTM Sep 202672.3% +1.9 pp+2.0 pp
KMTSKestra Medical Technologies, Ltd.LTM Jan 202648.8% +14.6 pp—
Peer median (excluding KMTS) 78.9%+1.9 pp+4.8 pp

Competitors are the stored peer set for KMTS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2020
Apr 2020
FY2021
Apr 2021
FY2023
Apr 2023
FY2024
Apr 2024
FY2025
Apr 2025
Revenue007.63M27.81M59.82M
Cost of Revenue0018.28M27.45M35.61M
Gross Profit00(10.65M)362K24.21M
Gross Margin——-139.6%1.3%40.5%
Research & Development22.8M18.81M15.76M15.49M15.65M
Selling, General & Admin6.52M13.9M54.01M69.94M114.94M
Operating Expenses29.32M32.71M69.77M85.43M130.59M
Depreciation & Amortization478K420K4.86M11.56M7.97M
EBITDA(28.84M)(32.33M)(73.74M)(76.31M)(97.98M)
EBITDA Margin——-966.4%-274.3%-163.8%
Operating Income(29.32M)(32.71M)(80.42M)(85.06M)(106.38M)
Operating Margin——-1054.0%-305.8%-177.8%
Interest Income00003.2M
Interest Expense01.17M5.63M6.23M7.73M
Other Income / Expenses0(1.21M)(3.8M)(9.03M)(7.3M)
Income Before Tax(29.32M)(33.91M)(84.22M)(94.1M)(113.68M)
Pre-Tax Margin——-1103.8%-338.3%-190.1%
Income Tax Expense148K187K15K24K135K
Net Income(29.47M)(34.1M)(84.24M)(94.12M)(113.81M)
Net Margin——-1104.0%-338.4%-190.3%
EPS (Basic)(0.59)(0.69)(1.75)(2.04)(5.13)
EPS (Diluted)(0.59)(0.69)(1.75)(2.04)(5.13)
Weighted Avg Shares49.53M49.53M49.53M49.53M49.53M
Weighted Avg Shares (Diluted)49.53M49.53M49.53M49.53M49.53M

Kestra Medical Technologies, Ltd.

NASDAQ:KMTS

Intrinsic Alpha fair value

Locked

Current Price

$28.29

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.